- Report
- August 2024
- 175 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Report
- April 2025
- 88 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- January 2025
- 146 Pages
Global
From €3744EUR$3,950USD£3,128GBP
- Report
- April 2025
- 194 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- June 2023
- 347 Pages
Global
From €4894EUR$5,344USD£3,950GBP
- Report
- November 2021
- 802 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Report
- November 2021
- 1184 Pages
Global
From €5687EUR$6,000USD£4,751GBP
€3254EUR$3,678USD£2,814GBP
- Book
- March 2020
- 160 Pages
- Book
- December 2024
- 560 Pages

Neurogenetics is a sub-field of genomics that focuses on the study of genetic factors that influence the development and function of the nervous system. It involves the identification of genetic variants associated with neurological disorders, as well as the development of new treatments and therapies. Neurogenetics research has the potential to improve the diagnosis and treatment of neurological diseases, as well as to provide insights into the underlying causes of these conditions.
Neurogenetics is a rapidly growing field, with a wide range of applications in both clinical and research settings. It is being used to identify genetic markers for neurological diseases, to develop new treatments and therapies, and to understand the underlying mechanisms of neurological disorders.
Companies in the Neurogenetics market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and PerkinElmer. Show Less Read more